Arcturus Therapeutics Holdings (ARCT) Shares Outstanding (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Shares Outstanding (Entity) data on file, last reported at $28.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 4.8% year-over-year to $28.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.4 million (up 4.8% YoY) and the FY2025 annual result came in at $28.4 million, up 4.86% from the prior year.
• Shares Outstanding (Entity) steadied at $28.4 million in Q1 2026, from $28.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $28.4 million in Q1 2026 to a low of $26555.0 in Q1 2023.
• A 5-year average of $22.3 million and a median of $26.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) slumped 99.9% — and 2024, when it surged 101819.17%.
• Tracing ARCT's Shares Outstanding (Entity) over 5 years: stood at $26.6 million in 2022, then grew by 1.03% to $26.8 million in 2023, then advanced by 1.0% to $27.1 million in 2024, then advanced by 4.86% to $28.4 million in 2025, then increased by 0.03% to $28.4 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $28.4 million (Q1 2026), $28.4 million (Q4 2025), and $27.2 million (Q3 2025), per Business Quant data.